An early stage VC fund based in the US currently has $250M under management. The group focuses on highly technical, very early stage companies. The typical investment size is between $1M to $2M and they’re open to lead, co-lead and follow. The group also syndicates with other investors for larger investments. The firm looks to make investments across the globe.
The firm have been highly active in deep tech/ R&D intensive investments, and have a significant biotech portfolio of notable/renowned companies in the industry.
Currently, the firm’s team is focusing on Neuroscience and brain tech, like Neuromodulation, BCI, precision neuroscience, and infra from data driven angles, like AI in drug development, Multi Omics, from Seed to Series A.
The firm focuses on investments in private companies and typically invests in pre-clinical and early clinical stage companies with strong and experienced management teams. The firm will take a board seat or observer seat occasionally, depending on the investments.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment